Repligen (NASDAQ:RGEN) initiated with Buy rating by C.L. King.
AVEO Pharmaceuticals (NASDAQ:AVEO) initiated with Buy rating and $5 (67% upside) price target by B. Riley FBR.
Bio-Path Holdings (NASDAQ:BPTH) price target lowered to $1.50 (384% upside) from $4.50 by H.C. Wainwright citing delay in Phase 2 AML data on prexigebersen.
BioSpecifics Technologies (NASDAQ:BSTC) price target lowered to $65 (49% upside) from $72 by H.C. Wainwright based on expectation of single-digit revenue growth.
Teva Pharmaceutical Industries (NYSE:TEVA) downgraded to Underweight with an $11 (7% downside risk) by JPMorgan. Shares are down 2% premarket on increased volume.
QuintilesIMS (NYSE:Q) downgraded to Sector Weight by KeyBanc.
Exact Sciences (NASDAQ:EXAS) downgraded to Neutral by Baird.
Mallinckrodt (NYSE:MNK) downgraded to Neutral by UBS.
Gilead Sciences (NASDAQ:GILD) downgraded to Hold by Argus Research.
Now read: Why Mallinckrodt Cratered »
Subscribe for full text news in your inbox